Table 1.
Association between NOK expressions and clinicopathological features in NSCLC patients
| Variables | No. of cases |
NOK expression |
||
|---|---|---|---|---|
| Positive (%) | Negative (%) | P -value * | ||
| Sex |
|
|
|
|
| Male |
154 |
114 (74.0) |
40 (26.0) |
0.371 |
| Female |
37 |
30 (81.1) |
7 (18.9) |
|
| Age |
|
|
|
|
| <60 |
90 |
70 (77.8) |
20 (22.2) |
0.470 |
| ≥60 |
101 |
74 (73.3) |
27 (26.7) |
|
| Smoking history |
|
|
|
|
| Smoker |
133 |
100 |
33 |
0.618 |
| Non-smoker |
58 |
42 |
16 |
|
| Differentiation |
|
|
|
|
| Well + moderately |
140 |
100 (71.4) |
40 (28.6) |
0.035 |
| Poorly |
51 |
44 (86.3) |
7 (13.7) |
|
| Histological type |
|
|
|
|
| Squamous |
98 |
71 (72.4) |
27 (27.6) |
0.332 |
| Adenocarcinoma |
93 |
73 (78.5) |
20 (21.5) |
|
| pT factor |
|
|
|
|
| T1–2 |
148 |
110 (74.3) |
38 (25.7) |
0.525 |
| T3–4 |
43 |
34 (79.1) |
9 (20.0) |
|
| pN factor |
|
|
|
|
| N0 |
88 |
58 (65.9) |
30 (34.1) |
0.005 |
| N1–2 |
103 |
86 (83.5) |
17 (16.5) |
|
| pTNM stage |
|
|
|
|
| I-II |
128 |
90 (70.3) |
38 (29.7) |
0.020 |
| III-IV |
63 |
54 (85.7) |
9 (14.3) |
|
| Ki-67 labeling index |
|
|
|
|
| <31 |
94 |
57 (60.6) |
37 (39.4) |
<0.001 |
| ≥31 | 97 | 89 (91.8) | 8 (8.2) | |
*P-value of χ2-test are shown.